Probing the Conformational Changes Associated with DNA Binding to PARP1
- 1 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 59 (21) , 2003-2011
Abstract
Poly-(ADP-ribose) polymerase 1 (PARP1) is an important first responder in the mechanism of DNA repair in eukaryotic cells. It is also a validated drug target, with three different PARP inhibitors (PARPi) approved for the treatment of BRCA-negative cancers. Despite past efforts, many aspects of PARPi are poorly understood, in particular their ability to trap PARP1 on chromatin, and the relationships between their potencies, cellular toxicities, and trapping efficiencies. Because PARP-trapping is widely believed to originate in allosteric coupling between DNA-binding and the catalytic site, we further investigated the binding properties of PARP1 to a model for DNA with a double strand break in the presence and absence of PARPi. Specifically, we have used sequential mixing stopped-flow spectroscopy to identify a slow conformational change that follows rapid DNA binding. Using a range of DNA concentrations and different mutants of PARP1 we demonstrate that this conformational change is one of the steps of the ‘monkey bar mechanism’ that promotes DNA-dependent dissociation of DNA. This conformational change also corresponds to the previously identified conformational change associated with DNA-dependent activation of PARP1. Despite linking the conformational change associated with DNA binding and release to DNA activation, we find no evidence for PARPi perturbing this allosteric coupling.Keywords
Funding Information
- Howard Hughes Medical Institute
- Center for Scientific Review (CA218255)
This publication has 33 references indexed in Scilit:
- Automodification switches PARP-1 function from chromatin architectural protein to histone chaperoneProceedings of the National Academy of Sciences, 2014
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and RucaparibMolecular Cancer Therapeutics, 2014
- Trapping of PARP1 and PARP2 by Clinical PARP InhibitorsCancer Research, 2012
- Alternative Modes of Binding of Poly(ADP-ribose) Polymerase 1 to Free DNA and NucleosomesJournal of Biological Chemistry, 2012
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPsNature Reviews Molecular Cell Biology, 2012
- Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1Science, 2012
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandingsMolecular Oncology, 2011
- Facilitated DNA Search by Multidomain Transcription Factors: Cross Talk via a Flexible LinkerBiophysical Journal, 2010
- A review of PARP inhibitors: from bench to bedsideAnnals of Oncology, 2010
- Binding kinetics and activity of human poly(ADP‐ribose) polymerase‐1 on oligo‐deoxyribonucleotide substratesJournal of Molecular Recognition, 2009